92
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Interleukin-6 and interleukin-8 blood levels’ poor association with the severity and clinical profile of ex-smokers with COPD

, , , &
Pages 735-743 | Published online: 29 Jul 2014

References

  • ManninoDMCOPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneityChest2002121Suppl 5121S126S12010839
  • PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
  • CosioMGSaettaMAgustiAImmunologic aspects of chronic obstructive pulmonary diseaseN Engl J Med2009360232445245419494220
  • FabbriLMRomagnoliMCorbettaLDifferences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167341842412426229
  • HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet2004364943570972115325838
  • SaettaMDi StefanoATuratoGCD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 18228269517597
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • AaronSDVandemheenKLRamsayTMulti analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPDRespir Res2010114120412595
  • Garcia-RioFMiravitllesMSorianoJBEPI-SCAN Steering CommitteeSystemic inflammation in chronic obstructive pulmonary disease: a population-based studyRespir Res2010116320500811
  • Piehl-AulinKJonesILindvallBMagnusonAAbdel-HalimSMIncreased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary diseaseRespiration200978219119619270439
  • HeZChenYChenPWuGCaiSLocal inflammation occurs before systemic inflammation in patients with COPDRespirology201015347848420210891
  • FerrariRTanniSECaramLMCorrêaCCorrêaCRGodoyIThree-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary diseaseRespir Res2013142423425215
  • Garcia-AymerichJGómezFPBenetMPAC-COPD Study GroupIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
  • AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
  • YaoHRahmanICurrent concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary diseaseToxicol Appl Pharmacol20112542728521296096
  • LiuJLiangQFrost-PinedaKRelationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokersCancer Epidemiol Biomarkers Prev20112081760176921708936
  • WillemseBWten HackenNHRutgersBPostmaDSTimensWAssociation of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokersRespir Res200563815850494
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD: GOLD Revised 2011 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Jan21.pdfAccessed May 20, 2011
  • Ciba Foundation Guest SymposiumTerminology, definition and classification of chronic pulmonary emphysema and related conditionsThorax1959144286299
  • MenezesAMEpidemiologia da bronquite crônica e do enfisema (DPOC): até onde sabemos? [Bronchitis and emphysema epidemiology: what do we know?]J Pneumol1997233153157 Portugese
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
  • PereiraCASatoTRodriguesSCNew reference values for forced spirometry in white adults in BrazilJ Bras Pneumol200733439740617982531
  • ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
  • DonaldsonGCSeemungalTARPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
  • CelliBRLocantoreNYatesJECLIPSE InvestigatorsInflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185101065107222427534
  • Pinto-PlataVCasanovaCMullerovaHInflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPDRespir Res2012137122906131
  • EickhoffPValipourAKissDDeterminants of systemic vascular function in patients with stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178121211121818836149
  • BreyerMKRuttenEPVernooyJHGender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptinRespir Med201110571046105321367591
  • CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
  • WagnerPDPossible mechanisms underlying the development of cachexia in COPDEur Respir J200831349250118310396
  • MoralesSADreyseDJDíazPOSaldíasPFCarrascoMLisboaBCSystemic inflammation among stable ex smokers with chronic obstructive pulmonary diseaseRev Med Chil20101388957964 Spanish21140052
  • de TorresJPPinto-PlataVCasanovaCC-reactive protein levels and survival in patients with moderate to very severe COPDChest200813361336134318339787
  • IzquierdoJLAlmonacidCParraTPérezJSystemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary diseaseArch Bronconeumol2006427332337 Spanish16945263
  • Van der VaartHPostmaDSTimensWAcute effects of cigarette smoking on inflammation in healthy intermittent smokersRespir Res200562215740629
  • WillemseBWten HackenNHRutgersBPostmaDSTimensWAssociation of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokersRespir Res200563815850494
  • WatzHWaschkiBKirstenAThe metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivityChest200913641039104619542257
  • ThomsenMDahlMLangePVestboJNordestgaardBGInflammatory biomarkers and comorbidities in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121861098298822983959
  • DivoMCoteCde TorresJPBODE Collaborative GroupComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
  • SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609